Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of Biomedical Science|February 16, 2010
In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow propertiesA Luquita, L Urli, M J Svetaz, et al.Minerva Chirurgica|May 10, 2003
[Day Surgery. Five years of experience and activity]L Ivaldi, M Perino, G Gambetta, et al.Minerva Chirurgica|April 15, 2003
[Jeiuno-ileal diverticula complicated by perforation. Clinical case]A Bianco, L Ivaldi, M Perino, et al.Biochimica Et Biophysica Acta|March 4, 2008
Lysophosphatidylcholine-arbutin complexes form bilayer-like structuresM A Frías, B Winik, M B Franzoni, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|December 2, 2011
From amorphous to crystalline silicon nanoclusters: structural effects on exciton propertiesL J Borrero-González, L A O Nunes, F E G Guimarães, et al.Journal of the National Cancer Institute|April 20, 2001
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative managementM Greco, F Crippa, R Agresti, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 27, 2004
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, C De Souza, S Aversa, et al.Clinical and Experimental Rheumatology|September 25, 2007
Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitisM Alpa, B Ferrero, R Cavallo, et al.Journal of Cancer Research and Clinical Oncology|May 15, 2020
Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?E La Rocca, E Meneghini, L Lozza, et al.Pageof 7